文献速递肾小球疾病遗传性与小管间质肾病

基于患者特异性方法的多组学分析揭示儿童肾病综合征激素抵抗的血浆蛋白与代谢标志物

Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" Approach.
PubMed 文献 · Kidney Int Rep · 2023-03-23

研究纳入治疗前采集血浆的儿童肾病综合征患者(激素敏感型8例,激素抵抗型7例),采用患者特异性生物信息学方法整合治疗前后配对的蛋白质组与代谢组数据。结果发现激素抵抗型患者存在烟酸/烟酰胺和丁酸代谢通路扰动,NAMPT、NMNAT1和SETMAR上调,而激素敏感型患者赖氨酸降解、黏蛋白型O-聚糖生物合成及糖酵解/糖异生通路扰动,ALDH1B1、ACAT1、AASS、ENPP1和丙酮酸上调。免疫印迹证实激素治疗后激素抵抗型NAMPT表达升高,激素敏感型ALDH1B1和ACAT1表达升高。

要点

  • 患者特异性多组学方法可整合蛋白质组与代谢组数据,识别单一组学未发现的候选激素抵抗标志物。
  • 激素抵抗型患者烟酸/烟酰胺和丁酸代谢通路扰动,NAMPT、NMNAT1和SETMAR上调。
  • 激素敏感型患者赖氨酸降解、黏蛋白型O-聚糖生物合成及糖酵解/糖异生通路扰动,ALDH1B1、ACAT1、AASS、ENPP1和丙酮酸上调。

核心结论

  • 患者特异性生物信息学方法可整合不同的组学数据集,识别单独蛋白质组或代谢组分析未观察到的候选激素抵抗型肾病综合征标志物。

研究设计与样本

  • 研究纳入治疗前采集血浆标本的儿童肾病综合征患者队列(激素敏感型8例,激素抵抗型7例),标本未经激素诱导的基因表达改变混杂。
  • 采用患者特异性生物信息学方法整合治疗前后配对的蛋白质组和代谢组数据,比较激素抵抗型与激素敏感型患者的候选标志物和分子通路改变。

主要发现

  • 联合通路分析显示激素抵抗型患者存在烟酸或烟酰胺及丁酸代谢通路扰动。
  • 激素敏感型患者存在赖氨酸降解、黏蛋白型O-聚糖生物合成及糖酵解或糖异生通路扰动。
  • 激素抵抗型患者NAMPT、NMNAT1和SETMAR上调,激素敏感型患者ALDH1B1、ACAT1、AASS、ENPP1和丙酮酸上调。
  • 丙酮酸调控为既往分析中已见的变化,其余靶点均为新发现。
  • 免疫印迹证实激素治疗后激素抵抗型NAMPT表达升高,激素敏感型ALDH1B1和ACAT1表达升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Nephrotic syndrome (NS) occurs commonly in children with glomerular disease and glucocorticoids (GCs) are the mainstay treatment. Steroid resistant NS (SRNS) develops in 15% to 20% of children, increasing the risk of chronic kidney disease compared to steroid sensitive NS (SSNS). NS pathogenesis is unclear in most children, and no biomarkers exist that predict the development of pediatric SRNS. METHODS: We studied a unique patient cohort with plasma specimens collected before GC treatment, yielding a disease-only sample not confounded by steroid-induced gene expression changes (SSNS n = 8; SRNS n = 7). A novel "patient-specific" bioinformatic approach merged paired pretreatment and posttreatment proteomic and metabolomic data and identified candidate SRNS biomarkers and altered molecular pathways in SRNS versus SSNS. RESULTS: Joint pathway analyses revealed perturbations in nicotinate or nicotinamide and butanoate metabolic pathways in patients with SRNS. Patients with SSNS had perturbations of lysine degradation, mucin type O-glycan biosynthesis, and glycolysis or gluconeogenesis pathways. Molecular analyses revealed frequent alteration of molecules within these pathways that had not been observed by separate proteomic and metabolomic studies. We observed upregulation of NAMPT, NMNAT1, and SETMAR in patients with SRNS, in contrast to upregulation of ALDH1B1, ACAT1, AASS, ENPP1, and pyruvate in patients with SSNS. Pyruvate regulation was the change seen in our previous analysis; all other targets were novel. Immunoblotting confirmed increased NAMPT expression in SRNS and increased ALDH1B1 and ACAT1 expression in SSNS, following GC treatment. CONCLUSION: These studies confirmed that a novel "patient-specific" bioinformatic approach can integrate disparate omics datasets and identify candidate SRNS biomarkers not observed by separate proteomic or metabolomic analysis.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Bhayana S, Zhao Y, Merchant M, et al. Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" Approach. Kidney Int Rep. 2023. PMID: 37284673. doi:10.1016/j.ekir.2023.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。